The PE Ratio as of November 2024 (TTM) for Bright Minds Biosciences Inc. (DRUG) is -80.30

According to Bright Minds Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -80.30. This represents a change of -35397.79% compared to the average of 0.23 of the last 4 quarters.

Bright Minds Biosciences Inc. (DRUG) Historical PE Ratio (quarterly & annually)

How has DRUG PE Ratio performed in the past?

The mean historical PE Ratio of Bright Minds Biosciences Inc. over the last ten years is -137.68. The current -80.30 PE Ratio has changed 5.73% with respect to the historical average. Over the past ten years (40 quarters), DRUG's PE Ratio was at its highest in in the June 2024 quarter at 6.97. The PE Ratio was at its lowest in in the March 2020 quarter at -1271.54.

Bright Minds Biosciences Inc. (DRUG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bright Minds Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bright Minds Biosciences Inc. (DRUG) Average PE Ratio

How has DRUG PE Ratio performed in the past?

The current PE Ratio of Bright Minds Biosciences Inc. (DRUG) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bright Minds Biosciences Inc. (DRUG) PE Ratio vs. Peers

How is DRUG’s PE Ratio compared to its peers?

Bright Minds Biosciences Inc.’s PE Ratio is less than Revelation Biosciences, Inc. (-0.09), less than Zura Bio Limited (-10.87), less than Phio Pharmaceuticals Corp. (-0.19), less than ZyVersa Therapeutics, Inc. (-0.07), less than TransCode Therapeutics, Inc. (-0.20), less than Pyxis Oncology, Inc. (-3.88), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Altamira Therapeutics Ltd. (-0.03), less than Elevation Oncology, Inc. (-0.78), less than Apexigen, Inc. (-0.36), less than Immix Biopharma, Inc. (-2.39), less than Virios Therapeutics, Inc. (-0.76), less than Navidea Biopharmaceuticals, Inc. (0.03), less than Aditxt, Inc. (-0.02), less than NeuroBo Pharmaceuticals, Inc. (-0.53), less than Dermata Therapeutics, Inc. (-0.08), less than Unicycive Therapeutics, Inc. (-0.62),

Build a custom stock screener for Bright Minds Biosciences Inc. (DRUG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bright Minds Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bright Minds Biosciences Inc. (DRUG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bright Minds Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.